The present invention relates to a medical device, and more particularly, the present invention relates to an implantable device for managing obstructive sleep apnea.
Obstructive Sleep Apnea (OSA) is a major cause of morbidity and mortality. It has been linked to a significant increase in the incidence of hypertension, cardiac disease, and cerebrovascular accidents. Besides creating discomfort for a partner because of snoring, patients usually suffer from daytime sleepiness and fatigue as their night sleep can be disrupted up to a few hundred times during an 8-hour sleep period.
Currently, the first line of treatment for OSA is using Continuous positive airway pressure therapy (CPAP) devices, where the patient has to wear a mask during sleep. Through this mask, the patient is subjected to a continuous positive airflow keeping the respiratory airway open. The CPAP mask itself is not well tolerated by the patients as it may itself disrupt sleep. This is because wearing the mask during sleep feels uncomfortable, leading to a low adherence rate. In severe cases, upper airway surgery is recommended, aiming at removing some of the tissues, which may or may not be successful in treating OSA and in itself may create some other complications. Another treatment is hypoglossal nerve stimulation (HNS), based on the principle of electrically stimulating the corresponding nerves. This approach involves surgically implanting an internal pulse generator device in the chest and connecting associated leads to the site of stimulation in the upper respiratory tissues. The eligibility criteria disallow usage for obese patients. Remarkably, obese subjects are the most affected by OSA.
A need is therefore appreciated for a novel mechanism to prevent obstructive sleep apnea in patients that is comfortable in use and thus results in positive patient compliance.
In this patent, an implantable system to prevent sleep apnea is described, which acts by creating a repulsive force between the involved respiratory airway tissues whenever apnea is detected. This repulsive force is generated by two opposing magnetic fields and is activated at the onset of sleep apnea.
The following presents a simplified summary of one or more embodiments of the present invention in order to provide a basic understanding of such embodiments. This summary is not an extensive overview of all contemplated embodiments and is intended to neither identify key or critical elements of all embodiments nor delineate the scope of any or all embodiments. Its sole purpose is to present some concepts of one or more embodiments in a simplified form as a prelude to the more detailed description that is presented later.
The principal object of the present invention is therefore directed to a device and method for managing obstructive sleep apnea in patients.
It is another object of the present invention that the device can be implanted.
In one aspect, disclosed is a device and method to manage obstructive sleep apnea in patients suffering from it. The device can include a first implantable member and a second implantable member, wherein both the first implantable member and the second implantable member can generate a magnetic field, such that when like poles of the first implantable member and the second implantable member face each other, the first implantable member and the second implantable member repel each other due to the opposing magnetic field.
In one aspect, the first implantable member can be implanted in a base of the tongue and the second implantable member can be implanted in a soft palate, such as the first implantable member and the second implantable member repel each other due to the magnetic field, and the repulsion between the first implantable member and the second implantable member can keep the airway open.
The accompanying figures, which are incorporated herein, form part of the specification and illustrate embodiments of the present invention. Together with the description, the figures further explain the principles of the present invention and to enable a person skilled in the relevant arts to make and use the invention.
The accompanying figures, which are incorporated herein, form part of the specification and illustrate embodiments of the present invention. Together with the description, the figures further explain the principles of the present invention and to enable a person skilled in the relevant arts to make and use the invention.
Furthermore, in the following description of embodiments, numerous specific details are set forth in order to provide a thorough understanding of the present technology. However, the present technology may come together in the form of a complete assembly without these specific details. In some instances, well-known methods, procedures, devices, and circuits have not been described in detail as not to unnecessarily obscure aspects of the present embodiments.
To simplify the descriptions, in terms of North and South magnetic poles, only one configuration has been described. It should be noted that the selection of the North/South poles for the magnetic fields is arbitrary and can be reversed. As such, in this document, all North poles can be replaced by South poles, and all South poles be replaced by North poles without affecting the overall result.
The location where the magnetic generating field elements are inserted is also one particular embodiment in this document, namely the soft palate and base of the tongue. It is understood that other tissues potentially involved in airway obstruction can also be selected to this end, but for the sake of simplifying this document are not repeated here.
Disclosed is a device and method for managing obstructive sleep apnea in patients suffering from it. The disclosed device and method can prevent the airway from collapsing during sleep, and without disturbing the sleep of the patient. The disclosed device can be implanted and thus does not interface or cause discomfort to the patient while sleeping. One or more aspects of the disclosed device can be automated and may not require any intervention from the patient for operating the device. Overall, patient compliance can be improved, and the incidents of medical emergencies can be significantly lowered in patients due to obstructive sleep apnea. The disclosed device can be adapted to people of different ages and body structures, such as for both thin and obese patients.
In one implementation, the disclosed device can include a first implantable member and a second implantable member wherein both the first implantable member and the second implantable member can be implanted in body tissues or organs related to the respiratory airway that are affected by obstructive sleep apnea or responsible for blocking the airway, such as a base of a tongue and a soft palate. Both the first implantable member and the second implantable member can generate magnetic fields, such that when the two members are positioned having their like magnetic poles facing each other, the two members repel each other. The repulsion of the two members when implanted in the base of the tongue and the soft palate can prevent the airway from collapsing i.e., can keep the airway open. It is understood that the magnetic field generated can be of sufficient strength to keep the airway open and may not be more that can cause any discomfort.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
In one implementation, the disclosed device and method can provide for automated operation using one or more sensors that can detect the onset of apnea in the patient, and in response to a signal from the sensor indicating the onset of apnea, the first implantable member and the second implantable member can be activated to generate repulsive magnetic fields which opens the airway and keeps it open. In one implementation, the two magnetic members can remain activated for a pre-determined duration and then can be deactivated, and upon deactivation of the two members, the sensors can be activated again. This process can be repeated for autonomous management of obstructive sleep apnea in patients. The sensors can be any sensors that can detect the onset of apnea. The sensors can be implantable or can be external to the body. Suitable examples of sensors can include proximity sensors, accelerometers, gyroscopes, and like that can detect a change in spatial positions or closeness between two objects. Vibration sensors can also be used that can detect vibrations produced in body tissues due to snoring or blockage of the airway. Noise sensors can also be used that can detect a change in breathing voices or snoring to detect the onset of apnea. Similar, respiration sensors can also be used to detect the onset of apnea. It is understood that all such sensors and other sensors known to a skilled person for detecting the onset of apnea are within the scope of the present invention. Suitable logical circuitry can also be provided and can be implanted or can be external to the human body. The logical circuitry can connect to the sensors and the two magnetic/implantable members through a wired or wireless connection. The logical circuitry upon receiving a signal from the sensors indicating the onset of apnea can activate the two magnetic members to generate the magnetic field, thus keeping the airway open. The two magnetic members (implantable members) can be activated and deactivated in a variety of ways, such as turning the power supply on and off. The predetermined duration for keeping the two magnetic members active can also be set in the logical circuitry. It is understood that the logic circuitry can be optional, and the sensors can be directly coupled to the two magnetic members for activation of the two magnetic members.
The different components of the device can be powered by single or multiple power sources. One or more of such power sources may be implanted. One or more power sources can be wireless. Other suitable examples of power sources can include implantable batteries. Any such means of powering the sensors, the logical circuitry, the first implantable member, and the second implantable member are within the scope of the present invention.
While the foregoing written description of the invention enables one of ordinary skill to make and use what is considered presently to be the best mode thereof, those of ordinary skill will understand and appreciate the existence of variations, combinations, and equivalents of the specific embodiment, method, and examples herein. The invention should therefore not be limited by the above-described embodiment, method, and examples, but by all embodiments and methods within the scope and spirit of the invention as claimed.
This application claims priority from the U.S. provisional patent application Ser. No. 63/123,966, filed on Dec. 10, 2020, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63123966 | Dec 2020 | US |